Profund Advisors LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Profund Advisors LLC

$2.59 Billion
Q3 2024

A detailed history of Profund Advisors LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Profund Advisors LLC holds 39,754 shares of ARWR stock, worth $737,039. This represents 0.03% of its overall portfolio holdings.

Number of Shares

39,754

Previous 32,003 24.22%

Holding current value

$737,039

Previous $831,000 7.46%

% of portfolio

0.03%

Previous 0.03%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$19.36 - $29.54 $150,059 - $228,964	7,751 Added 24.22%	39,754 $769,000
Q2 2024 Aug 13, 2024	SELL	$21.87 - $28.24 $370,849 - $478,865	-16,957 Reduced 34.63%	32,003 $831,000
Q1 2024 May 08, 2024	SELL	$27.21 - $39.48 $397,075 - $576,131	-14,593 Reduced 22.96%	48,960 $1.4 Million
Q4 2023 Feb 14, 2024	BUY	$21.2 - $31.03 $204,283 - $299,005	9,636 Added 17.87%	63,553 $1.94 Million
Q3 2023 Nov 13, 2023	BUY	$26.2 - $36.08 $178,946 - $246,426	6,830 Added 14.51%	53,917 $1.45 Million
Q2 2023 Aug 10, 2023	SELL	$25.16 - $41.38 $143,789 - $236,486	-5,715 Reduced 10.82%	47,087 $1.68 Million
Q1 2023 May 11, 2023	BUY	$23.68 - $38.51 $824,135 - $1.34 Million	34,803 Added 193.36%	52,802 $1.34 Million
Q4 2022 Feb 02, 2023	BUY	$28.0 - $40.56 $14,644 - $21,212	523 Added 2.99%	17,999 $730,000
Q3 2022 Nov 04, 2022	SELL	$29.63 - $48.31 $9,363 - $15,265	-316 Reduced 1.78%	17,476 $578,000
Q2 2022 Aug 01, 2022	SELL	$27.79 - $50.61 $71,336 - $129,915	-2,567 Reduced 12.61%	17,792 $626,000
Q1 2022 May 10, 2022	SELL	$39.62 - $69.97 $81,339 - $143,648	-2,053 Reduced 9.16%	20,359 $936,000
Q4 2021 Feb 08, 2022	SELL	$58.09 - $82.51 $144,469 - $205,202	-2,487 Reduced 9.99%	22,412 $1.49 Million
Q3 2021 Nov 12, 2021	BUY	$58.38 - $84.96 $958,599 - $1.4 Million	16,420 Added 193.65%	24,899 $1.55 Million
Q2 2021 Aug 12, 2021	SELL	$62.15 - $90.32 $14,978 - $21,767	-241 Reduced 2.76%	8,479 $702,000
Q1 2021 May 14, 2021	SELL	$61.35 - $90.47 $71,963 - $106,121	-1,173 Reduced 11.86%	8,720 $578,000
Q4 2020 Feb 09, 2021	BUY	$43.82 - $85.37 $27,475 - $53,526	627 Added 6.77%	9,893 $759,000
Q3 2020 Nov 13, 2020	BUY	$33.21 - $51.27 $111,485 - $172,113	3,357 Added 56.81%	9,266 $399,000
Q2 2020 Aug 03, 2020	BUY	$26.12 - $43.27 $154,343 - $255,682	5,909 New	5,909 $255,000
Q1 2020 May 15, 2020	SELL	$20.56 - $63.12 $195,607 - $600,523	-9,514 Closed	0 $0
Q4 2019 Feb 18, 2020	SELL	$28.14 - $73.01 $1,519 - $3,942	-54 Reduced 0.56%	9,514 $603,000
Q3 2019 Nov 12, 2019	BUY	$26.26 - $34.86 $7,300 - $9,691	278 Added 2.99%	9,568 $270,000
Q2 2019 Aug 13, 2019	BUY	$17.43 - $28.82 $161,924 - $267,737	9,290 New	9,290 $246,000

Others Institutions Holding ARWR

# of Institutions

295

Shares Held

91.1M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.96B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.

Account

Profund Advisors LLC Arrowhead Pharmaceuticals, Inc. Transaction History